Skip to content

D68.32

Billable

Hemorrhagic disorder due to extrinsic circulating anticoagulants

HCC Category Mapping

V24HCC 48Coagulation Defects and Other Specified Hematological Disorders
0.209
ESRDHCC 48Coagulation Defects and Other Specified Hematological Disorders
0.000

What This Code Means

A bleeding disorder caused by blood-thinning medications or substances that circulate in the bloodstream and interfere with normal clotting.

Coding Tips

  • Document the specific anticoagulant agent (warfarin, heparin, etc.) in the medical record for accurate coding
  • This code is used when anticoagulant therapy causes bleeding complications; link to the medication code if applicable

Clinical Significance

Hemorrhagic disorder due to extrinsic circulating anticoagulants captures bleeding complications from anticoagulant medications such as warfarin, heparin, direct oral anticoagulants, and other antithrombotic agents. This is a common clinical scenario given widespread anticoagulant use. It reflects the medication's intended mechanism causing unintended excessive anticoagulation and hemorrhage.

Documentation Requirements

  • Document the specific anticoagulant medication causing the hemorrhagic disorder, INR or anti-Xa level at the time of bleeding, the anatomic site and severity of hemorrhage, and reversal agent used (vitamin K, protamine, idarucizumab, andexanet alfa, PCC).
  • Record adverse effect coding with the appropriate T-code for the causative medication.

Use Additional Code

  • code for adverse effect, if applicable, to identify drug (T45.515, T45.525)

Commonly Confused Codes

Code Hierarchy

Open D68.32 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.